EWB

Exhibition World Bahrain Secures "World’s Leading New Exhibition and Convention Centre 2023" Award at World Travel Awards 2023

Retrieved on: 
Sunday, December 3, 2023
Bahrain International Circuit, Conference, Travel, Airport, International Association, MICE, UFI, Convention, HE, EWB, PCMA, GDP, Exhibition, ICCA, WTA, Sport, Bahrain International Airport, Growth, Aviation, Convention center, BTEA, Arabesque, Tourism, Formula One, BIC

DUBAI, United Arab Emirates, Dec. 03, 2023 (GLOBE NEWSWIRE) -- Exhibition World Bahrain (EWB), the Middle East’s newest and largest exhibition and convention centre, is proud to announce securing the “World’s Leading New Exhibition and Convention Centre 2023” at the World Travel Awards 2023.

Key Points: 
  • DUBAI, United Arab Emirates, Dec. 03, 2023 (GLOBE NEWSWIRE) -- Exhibition World Bahrain (EWB), the Middle East’s newest and largest exhibition and convention centre, is proud to announce securing the “World’s Leading New Exhibition and Convention Centre 2023” at the World Travel Awards 2023.
  • Exhibition World Bahrain captured the highest number of votes, clinching the internationally recognised award from Bharat Mandapam, India, and Tākina Wellington Convention and Exhibition centre, New Zealand.
  • Winning the “World’s Leading New Exhibition and Convention Centre 2023” award coincides with EWB’s 1st anniversary and celebrates a remarkable set of milestones.
  • Additionally, EWB will host the 29th edition of Routes World, one of the world’s biggest civil aviation expos, for the first time in Bahrain.

Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
Tuesday, August 8, 2023
Rosacea, EWB, Total, PPR, SG, Marketing, Food and Drug Administration, Clinical trial, NDA, GAAP, Minocycline, Research and development, Capsule, EBITDA, Patient, Standard of care, Research, Adjustment, FDA, Therapy, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Safety, Video game, Pharmaceutical industry, Doxycycline

SCOTTSDALE, Ariz., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the second quarter ended June 30, 2023.

Key Points: 
  • ET
    SCOTTSDALE, Ariz., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the second quarter ended June 30, 2023.
  • Claude Maraoui, Journey Medical’s Co-Founder, President and Chief Executive Officer, said, “In the second quarter of 2023, our total net revenues were $17.2 million, a 41% increase from $12.2 million in the first quarter.
  • Selling, general and administrative expenses (“SG&A”) decreased by $3.0 million, or 20%, to $12.1 million for the second quarter 2023, from $15.2 million for the second quarter 2022.
  • Research and Development (“R&D”) expenses decreased by $0.8 million, or 32%, to $1.8 million for the second quarter 2023, from $2.6 million for second quarter 2022.

Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
Monday, May 22, 2023
News, EWB, PPR, Marketing, Clinical trial, NDA, Journey, GAAP, Minocycline, Security, EBITDA, IGA, New Çeltek events, Investment, Research, Adjustment, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, Rosacea, Food, Communications satellite, Pharmaceutical industry, Glycopyrronium tosylate

SCOTTSDALE, Ariz., May 22, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2023.

Key Points: 
  • ET
    SCOTTSDALE, Ariz., May 22, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2023.
  • In addition, all products were unfavorably impacted by higher gross-to-net adjustments compared to the first quarter of 2022.
  • In January 2023, Journey Medical completed enrollment in its DFD-29 Phase 3 clinical program for the treatment of PPR and achieved the “Last Patient Out” milestone in May 2023.
  • Journey Medical management will conduct a conference call and audio webcast on May 22, 2023, at 4:30 p.m.

Trimble Partners with Engineers Without Borders USA to Support Climate Resiliency and Education Efforts

Retrieved on: 
Thursday, February 23, 2023
Climate change, Housing, University, Engineers Without Borders – USA, Science, technology, engineering, and mathematics, TRMB, Trimble, Science, EWB, Heat, Education, STEM, Renewable energy, Engineering

WESTMINSTER, Colo., Feb. 23, 2023 /PRNewswire/ -- Trimble (NASDAQ: TRMB) and the Trimble Foundation announced today continued support for Engineers Without Borders USA (EWB-USA). The Foundation grant focuses on EWB-USA's climate resiliency projects and advancing its Science, Technology, Engineering and Math (STEM) education initiatives. The grant also extends support to EWB Student Chapters at universities with Trimble Technology Labs. The collaboration expands Trimble's ongoing support of EWB-USA's mission to develop engineering projects to build a better world.

Key Points: 
  • WESTMINSTER, Colo., Feb. 23, 2023 /PRNewswire/ -- Trimble (NASDAQ: TRMB) and the Trimble Foundation announced today continued support for Engineers Without Borders USA (EWB-USA).
  • The Foundation grant focuses on EWB-USA's climate resiliency projects and advancing its Science, Technology, Engineering and Math (STEM) education initiatives.
  • The grant also extends support to EWB Student Chapters at universities with Trimble Technology Labs.
  • The combination provides a unique opportunity for climate resiliency work by empowering the next generation to deliver impactful projects worldwide.

Ladrigan Management Arranges Financing with East West Bank in Support of Element Partners' $15 Million Recapitalization of Detechtion Technologies

Retrieved on: 
Wednesday, March 16, 2022
DCM, Growth, APM, Solution, Software as a service, Software, Essendon, Victoria, Industrial internet of things, Senior, EWB, Cryptocurrency, Creative industries

Since 1999, thousands of users have depended on Detechtion to optimize over 10,000 assets worldwide.

Key Points: 
  • Since 1999, thousands of users have depended on Detechtion to optimize over 10,000 assets worldwide.
  • We are excited to partner with Ladrigan and EWB on the transaction as we grow the Detechtion platform."
  • Reza Sabahi, Senior Managing Director of Commercial Capital added, "Detechtion is an exciting investment opportunity for East West Bank and a strong fit given our experience lending to high-growth SaaS businesses."
  • A lower middle market debt capital markets ("DCM") advisory, Ladrigan Management has deep experience on both sides of the table in DCM negotiations.

Ethic, A Wealth Bank Names William Buccella as President and Chief Executive Officer

Retrieved on: 
Wednesday, February 23, 2022
Banking, Professional Services, Finance, Board, Museum, Central Waqf Council, US Market Access Center, Industry, BS, EWB, Asia Wealth Bank, Bank, LinkedIn, Wilmington Trust, Institute, Board of directors, MBA, History, CEO, Babson College, High-net-worth individual, Management, Financial services, Boston College, Maria Grazia Buccella, Ethics

Ethic, A Wealth Bank (EWB), today announced the appointment of William Buccella as President and Chief Executive Officer (CEO), effective January 26, 2022.

Key Points: 
  • Ethic, A Wealth Bank (EWB), today announced the appointment of William Buccella as President and Chief Executive Officer (CEO), effective January 26, 2022.
  • In addition, Buccella was named to the Boards of Directors of the Bank and its holding company.
  • Buccella, in collaboration with EWBs existing leadership team, will lead the Bank as it continues its industry-leading approach to high-net-worth private banking.
  • He has held executive level positions at several financial institutions, managing a number of teams throughout this career.

Drip Capital Raises $175M to Build a Tech-Enabled Global Trade Facilitation Platform

Retrieved on: 
Thursday, October 28, 2021
Series, TI, Sequoia, Technology, Geography, Barclays, PALO, Founders Fund, Accel, Barclays Investment Bank, Partnership, Capital market, Y Combinator, SME, Nasdaq, Company, Pressure, CEO, Economics, COVID-19, Growth, First Round Capital, EWBC, Solution, EWB, CB Insights, Super Mario, LogDNA, Security (finance), Bank, Cryptocurrency, Online shopping

Founded in 2016, Drip Capital aims to solve the $3 trillion global trade finance gap.

Key Points: 
  • Founded in 2016, Drip Capital aims to solve the $3 trillion global trade finance gap.
  • To date, the company has financed more than $2 billion worth of global trade transactions spanning 80+ countries.
  • This strain is being felt most by SMBs who have never had easy access to capital," said Pushkar Mukewar, CEO and Co-founder of Drip Capital.
  • "We are proud to strengthen our partnership with Drip Capital and excited to support their vision for building the preeminent global trade platform," said Alex Bangash Managing Partner of TI Platform.

Rob Bredahl Takes up CEO Role at TigerRisk, Rod Fox Becomes Executive Chairman and Tim Ronda Is Named President

Retrieved on: 
Monday, October 4, 2021
Consulting, Professional Services, Insurance, Finance, Third Point Management, Insurance, CPCU, Partner (business rank), Allstate, Partner, Sale, Tiger, Middlebury College, Wharton School of the University of Pennsylvania, U.S. Securities and Exchange Commission, SIPC, QBE, PFG, Securities & Exchange Commission of Pakistan, London Stock Exchange, JUA, Board, Industry, CEO, University, Acquisition, TCMA, Growth, FINRA, Risk, Navy, Barclays Investment Bank, RenaissanceRe, Traction, Raleigh, North Carolina, Executive, Benfield Group, Uniform Securities Agent State Law Exam, Wendell Pritchett, IRONMAN, EWB, Management, Security (finance), Financial services

TigerRisk Partners LLC, a leading risk, capital and strategic advisor to the global insurance and reinsurance industries, has today announced that Rob Bredahl will become Chief Executive Officer, while current CEO Rod Fox takes on the role of Executive Chairman, effective immediately.

Key Points: 
  • TigerRisk Partners LLC, a leading risk, capital and strategic advisor to the global insurance and reinsurance industries, has today announced that Rob Bredahl will become Chief Executive Officer, while current CEO Rod Fox takes on the role of Executive Chairman, effective immediately.
  • Following the announcement that Tim Ronda will join TigerRisk starting October 14, he will be named President upon joining.
  • Mr. Bredahl, who was formerly President, joined TigerRisk in 2019, with the strategic goal of succeeding Mr. Fox as CEO.
  • This is an exciting time for the company, said Executive Chairman Mr. Fox.

Ingersoll Rand and Engineers Without Borders Make Life Better through Strategic Partnership to Build Resilient Communities around the World

Retrieved on: 
Monday, May 10, 2021
Environment, Construction & Property, Engineering, Utilities, Manufacturing, Building Systems, Philanthropy, Energy, Other Philanthropy, Development charities, Organizations, Engineers Without Borders, Non-profit organizations, EWB, Ingersoll, LinkedIn, IR, Ingersoll Rand Inc., Engineers Without Borders, INGERSOLL RAND INC., ENGINEERS WITHOUT BORDERS

b"In its latest release of environmental, social and governance (ESG) efforts, Ingersoll Rand Inc. (NYSE: IR) has partnered with Engineers Without Borders (EWB) to globally focus on sustainable community development and infrastructure.

Key Points: 
  • b"In its latest release of environmental, social and governance (ESG) efforts, Ingersoll Rand Inc. (NYSE: IR) has partnered with Engineers Without Borders (EWB) to globally focus on sustainable community development and infrastructure.
  • EWB is a nonprofit humanitarian organization building a better world through engineering projects that help lift communities out of poverty.
  • The expertise Ingersoll Rand brings will enable us to build more resilient communities through sustainable infrastructure projects,\xe2\x80\x9d said Jackie O\xe2\x80\x99Brien, chief executive officer of EWB.\nIngersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to helping make life better for our employees, customers and communities.
  • For more information visit ewb-usa.org and connect on Engineers Without Borders USA on Facebook , LinkedIn and Twitter .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210510005463/en/\n"

Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank

Retrieved on: 
Monday, April 5, 2021
Fortress Biotech, Receivables, Scottsdale, Arizona, EWB

SCOTTSDALE, Ariz. and NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Journey Medical), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (Fortress), today announced that it has entered into an agreement with East West Bank (EWB) in which EWB will provide a $7.5 million working capital line of credit.

Key Points: 
  • SCOTTSDALE, Ariz. and NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Journey Medical), a partner company of Fortress Biotech, Inc. (NASDAQ: FBIO) (Fortress), today announced that it has entered into an agreement with East West Bank (EWB) in which EWB will provide a $7.5 million working capital line of credit.
  • The line of credit is secured by Journey Medicals receivables and cash.
  • Journey Medical intends to use the proceeds for general corporate purposes, including the advancement of the Companys portfolio.
  • Journey Medical Corporation (Journey Medical) is focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model.